Andrea Maialetti

Andrea Maialetti

Auto-generated profile, based on publicly available information

Andrea Maialetti

Epilepsy Center, Istituto Nazionale Tumori Regina Elena, Roma, Italy

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2012 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
Laura PiccardiLaura Piccardi
Laura Piccardi
FBF. Bianchini
F. Bianchini
OAOrnella Argento
Ornella Argento
ANA. De Nigris
A. De Nigris
AMA. Maialetti
A. Maialetti
Cecilia GuarigliaCecilia Guariglia
Cecilia Guariglia


28 March 2018 in Frontiers in Neuroscience
Verified
Journal Article
Open access
Raffaella NoriRaffaella Nori
Raffaella Nori
LPLaura Piccardi
Laura Piccardi
AMAndrea Maialetti
Andrea Maialetti
MGMirco Goro
Mirco Goro
ARAndrea Rossetti
Andrea Rossetti
Cecilia GuarigliaCecilia Guariglia
Cecilia Guariglia
The present study has two-fold aims: to investigate whether gender differences persist even when more time is given to acquire spatial information; to assess the gender effect when the retrieval phase requires recalling the pathway from the same or a different reference perspective (egocentric or allocentric). Specifically, we analyse the performance of men and women while learning a path from a map or by observing an experimenter in a real environment. We then asked them to reproduce the learned path using the same reference system (map learning vs. map retrieval or real environment learning vs. real environment retrieval) or using a different reference system (map learning vs. real environment retrieval or vice versa). The results showed that gender differences were not present in the retrieval phase when women have the necessary time to acquire spatial information. Moreover, using the egocentric coordinates (both in the learning and retrieval phase) proved easier than the other conditions, whereas learning through allocentric coordinates and then retrieving the environmental information using egocentric coordinates proved to be the most difficult. Results showed that by manipulating familiarity, gender differences disappear, or are attenuated in all conditions.

25 January 2021 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
AGAnna Rita Giovagnoli
Anna Rita Giovagnoli
APAnnalisa Parente
Annalisa Parente
RCRoberta Ciuffini
Roberta Ciuffini
GTGiulia Maria Tallarita
Giulia Maria Tallarita
KTKatherine Turner
Katherine Turner
TAthe Study Group on Cognitive Neurology, Neuropsychology – Adult Section of the Italian League AgainstEpilepsy
the Study Group on Cognitive Neurology, Neuropsychology – Adult Section of the Italian League AgainstEpilepsy

1 May 2017 in Clinical Neuropharmacology
Verified
Journal Article
Closed access
PDF file
MMMarta Maschio
Marta Maschio
LDLoredana Dinapoli
Loredana Dinapoli
AZAlessia Zarabla
Alessia Zarabla
AMAndrea Maialetti
Andrea Maialetti
DGDiana Giannarelli
Diana Giannarelli
TCTonino Cantelmi
Tonino Cantelmi
Objectives: Epilepsy heavily affects the quality of life (QoL) of patients with brain tumor because in addition to taking treatments for the oncological illness, patients are required to live with the long-term taking of antiepileptic drugs (AEDs). The AEDs' adverse effects are common in these patients and can negatively influence their perceptions of their QoL. We conducted an observational pilot study in patients with brain tumor–related epilepsy to verify efficacy, tolerability, and impact on QoL and global neurocognitive performances of zonisamide (ZNS) in add-on. Materials and Methods: We recruited 13 patients (5 females, 8 males; mean age, 49.6 years) presenting uncontrolled seizures. At first visit and at final follow-up at 6 months, patients underwent neurological examination, evaluation of adverse events, and cognitive and QoL tests. A seizure diary was given. Results: Eight patients underwent chemotherapy, 3 underwent radiotherapy, and 5 had disease progression. Mean dosage of ZNS at final follow-up was 300 mg/d. Of 9 patients who reached the sixth month follow-up, the mean weekly seizure number before ZNS had been 3.2 ± 5.0, and at final follow-up, the mean weekly seizure number was 0.18 ± 0.41 (P = 0.05). Compared with baseline, we observed stability in all cognitive domains, except for verbal fluency that significantly worsened. Results on QoL tests showed that QoL remained unchanged over time, which could indicate that ZNS did not influence the patients' perceived QoL. Conclusions: Zonisamide as add-on in our patients seems to be well tolerated and efficacious in controlling seizures. Despite having limitations represented by the fact that our study is observational, with a small study population and a short follow-up period, our results confirm that when choosing an AED, in addition to efficacy, the drug's effect on patients' QoL also needs to be considered, especially for patients facing many psychosocial challenges, such as those with brain tumor–related epilepsy.

11 February 2020 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
AMAndrea Maialetti
Andrea Maialetti
MMMarta Maschio
Marta Maschio
AZAlessia Zarabla
Alessia Zarabla
CPCamilla Polimadei
Camilla Polimadei
EPElena Papa
Elena Papa
DGDiana Giannarelli
Diana Giannarelli